← All stocks

Theravance Biopharma, Inc.

TBPH No buying or selling
CIK 0001583107 #2645 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

13 insiders · 0 transactions
26.5×

Rick E Winningham holds 26.5 times base salary in stock. $27.79M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Rick E Winningham last reported holding, valued at $17.00, the price COM was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Samaha Eli
10% owner
9,174,453
17.67%
$155.98M
−3.5%
Winningham Rick E
CHIEF EXECUTIVE OFFICER
1,634,422
3.15%
$27.79M
−10.6%
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
355,168
0.6841%
$6.04M
+3.7%
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
336,841
0.6488%
$5.73M
+4.8%
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
226,790
0.4368%
$3.86M
−30.6%
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
189,826
0.3656%
$3.23M
+18.2%
MITCHELL DEAN J
Director
97,213
0.1872%
$1.65M
+20.7%
Smaldone Alsup Laurie
Director
80,989
0.1560%
$1.38M
+25.9%
O'Connor Donal
Director
80,213
0.1545%
$1.36M
+26.2%
PAKIANATHAN DEEPIKA
Director
64,074
0.1234%
$1.09M
+35.1%
GRAY SUSANNAH
Director
48,146
0.0927%
$818.54K
+52.9%
BROSHY ERAN
Director
44,703
0.0861%
$760.00K
−63.5%
Grant Jeremy T
Director
32,954
0.0635%
$560.26K
+47.7%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 48,023
History held since 22 Nov 2016